Skip to main content
Clinical Trials/ACTRN12618001144202
ACTRN12618001144202
Completed
N/A

Closed-loop oxygen control using a novel nasal high flow device during a six minute walk test in participants with chronic respiratory disease.

Fisher and Paykel Healtcare0 sites42 target enrollmentJuly 12, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Fisher and Paykel Healtcare
Enrollment
42
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 12, 2018
End Date
July 2, 2019
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Fisher and Paykel Healtcare

Eligibility Criteria

Inclusion Criteria

  • Doctor’s diagnosis of chronic respiratory disease, such as chronic obstructive pulmonary disease (COPD), interstitial lung disease or bronchiectasis
  • Age \>18 years
  • SpO2 \<90% during 6 minute walk test, demonstrated at visit one.
  • Stable respiratory state with no exacerbation in last 4 weeks

Exclusion Criteria

  • Requirement for long term oxygen therapy (LTOT) or SpO2 \<92% at rest
  • Presence of any absolute or relative (at investigator discretion) contraindications to 6 minute walk test as per ATS/ERS technical standard
  • Diagnosis of a notifiable disease
  • Infection or colonization with multidrug resistant bacteria, Pseudomonas species, Burkholderia Cepacia or mycobacteria
  • The presence of an implantable Medical Device
  • Any other condition which, at the investigator’s discretion, is believed may present a safety risk or impact the feasibility of the study or the study results.

Outcomes

Primary Outcomes

Not specified

Similar Trials